# Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department

> **NCT06229353** · — · TERMINATED · sponsor: **University of Alabama at Birmingham** · enrollment: 34 (actual)

## Conditions studied

- Human Papilloma Virus

## Interventions

- **BIOLOGICAL:** Gardasil 9

## Key facts

- **NCT ID:** NCT06229353
- **Lead sponsor:** University of Alabama at Birmingham
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2024-08-08
- **Primary completion:** 2025-07-30
- **Final completion:** 2025-07-30
- **Target enrollment:** 34 (ACTUAL)
- **Why stopped:** Slow pace of recruitment
- **Last updated:** 2026-04-20

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06229353

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06229353, "Developing and Evaluating a Novel Approach to Improve HPV Vaccination Coverage Among High-risk, Under-immunized Adults Via the Emergency Department". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT06229353. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*